. Elevated levels of plasma oxalate derived from endogenous (predominantly hepatic) biosynthesis and from dietary sources were filtered by the glomerulus, producing hyperoxaluria and urinary supersaturation with calcium oxalate, leading in turn to calcium oxalate precipitation, nephrocalcinosis, and nephrolithiasis.
2Ϫ , or 36 Cl Ϫ . Rate constants for 36 Cl Ϫ efflux into extracellular Cl Ϫ , SO 4 2Ϫ , and oxalate were uniformly 10-fold lower than for oppositely directed exchange. Acidic extracellular pH (pHo) inhibited all modes of hSLC26A2-mediated anion exchange. In contrast, acidic intracellular pH (pHi) selectively activated exchange of extracellular Cl Ϫ for intracellular 35 SO 4 2Ϫ but not for intracellular 36 Cl Ϫ or [ 14 C]oxalate. Protein kinase C inhibited hSLC26A2 by reducing its surface abundance. Diastrophic dysplasia mutants R279W and A386V of hSLC26A2 exhibited similar reductions in uptake of both 35 SO 4 2Ϫ and [ 14 C]oxalate. A386V surface abundance was reduced, but R279W surface abundance was at wild-type levels. chondrodysplasia; nephrolithiasis; oxalosis; anion exchange; Xenopus oocyte THE GENE FAMILY SLC26/SulP encodes anion exchangers and channels (12) expressed throughout evolution. Mutations in several SLC26 genes have been associated with human disease, including chondrodysplasia [SLC26A2 (22) ], diarrhea [SLC26A3; (24) ], and deafness [SLC26A4 (13) (27) and Slc26a1 Ϫ/Ϫ (10a)].
Nephrolithiasis in the Slc26a6
Ϫ/Ϫ mouse was associated with enteric absorptive hyperoxaluria secondary to selective reduction of intestinal oxalate secretion by 50 -75%, with unchanged rates of oxalate absorption (27, 44) . Elevated levels of plasma oxalate derived from endogenous (predominantly hepatic) biosynthesis and from dietary sources were filtered by the glomerulus, producing hyperoxaluria and urinary supersaturation with calcium oxalate, leading in turn to calcium oxalate precipitation, nephrocalcinosis, and nephrolithiasis.
Pharmacological reduction of hepatic oxalate biosynthesis should reduce hyperoxaluria, but such inhibitors are currently unavailable. Restriction of dietary oxalate has been proposed as an approach to reduce hyperoxaluria, but the proportion of urinary oxalate excretion attributable to the diet has been estimated to range between 5% and 40% (25) , and lifetime compliance is difficult. Thus, attempts to stimulate intestinal oxalate secretion, and/or to inhibit intestinal oxalate reabsorption, continue to constitute important therapeutic approaches to divert plasma oxalate from the urine by increasing fecal oxalate excretion.
The molecular identities of enteric oxalate absorption pathways remain unknown, as do those of the apparently Slc26a6-independent pathways mediating oxalate secretion into the intestinal lumen. Intestinal SLC26A3/DRA, although primarily an apical Cl Ϫ /HCO 3 Ϫ exchanger, is capable of some oxalate transport (2, 7) . mRNA encoding the chondrodysplasia gene SLC26A2/DTDST (diastrophic dysplasia sulfate transporter) is expressed not only in cartilage and chondrocytes but in the small intestine of rats (37) and in the colon and other tissues of humans (20, 22) . SLC26A2/DTDST polypeptide was detected at substantial levels at the apical pole of human enterocytes (20) , in rat renal proximal tubule brush border (5) , as well as in chondrocytes and many other cell types (20, 31) .
SLC26A2 was discovered as a SO 4 2Ϫ uptake transporter in human chondrocytes (22) and is expressed in chondrocytes, fibroblasts, and osteoblasts of the mouse (14) . 35 
SO 4
2Ϫ efflux from rat chondrocytes was noted to require the presence of extracellular Cl Ϫ (37) . Functional studies of recombinant SLC26A2 have been restricted to 35 SO 4 2Ϫ uptake assays in Xenopus oocytes (29, 37) and in human embryonic kidney (HEK)-293 cells (28) . The oocyte studies have demonstrated cis-inhibition by Cl Ϫ and HCO 3 Ϫ (100 mM), by SO 4 2Ϫ , thiosulfate, and oxalate (5 mM), and by DIDS (1 mM) (37) . However, tests of anion exchange and oxalate transport by recombinant SLC26A2 have not yet been published. hSLC26A2 and mSlc26a2 polypeptides, although of identical length, share only 80% amino acid identity, a degree of divergence previously shown for SLC26A6 (at 78%) to encode substantial differences in function. We have therefore extended the functional characterization of both human SLC26A2 (hSLC26A2) and mouse Slc26a2 (mSlc26a2) and tested the hypothesis that they transport oxalate. Solutions. MBS consisted of (in mM) 85 NaCl, 1 KCl, 2.4 NaHCO 3, 0.82 Mg(SO4)2, 0.33 Ca(NO3)2, 0.41 CaCl2, and 10 HEPES (pH adjusted to 7.40 with NaOH). ND-96 (pH 7.40) consisted of (in mM) 96 NaCl, 2 KCl, 1.8 CaCl 2, 1 MgCl2, and 5 HEPES. In Cl Ϫ -free ND-96 or partial Cl Ϫ substitution solutions, NaCl was replaced mole-for-mole with Na cyclamate or, in the case of two-electrode voltage-clamp experiments, Na gluconate. In some experiments, 96 mM NaCl was replaced with 64 mM Na 2SO4 2Ϫ . As needed, the Cl Ϫ salts of K ϩ , Ca 2ϩ , and Mg 2ϩ were substituted on an equimolar basis with the corresponding gluconate salts. Na oxalate-containing bath solutions were nominally Ca 2ϩ free. Addition to flux media of the weak acid salt sodium butyrate (40 mM) was in equimolar substitution for Na cyclamate. Bath addition of NH 4Cl (20 mM) was in equimolar substitution for NaCl. pH 5.0 ND96 solutions were buffered with 5 mM MES. (Occasional use of 5 mM HEPES during the four 1-min exposures to pH 5.0 was without bath pH drift and without change in results.)
Construction and mutagenesis of cDNA expression plasmids. Human SLC26A2/DTDST (hSCL26A2) cDNA in a modified pGEM vector as described (29) was subcloned into the Xenopus oocyte expression vector pXT7. Mouse Slc26a2 (mSlc26a2) cDNA in pCMV-SPORT6 (clone ID 4014785; BC028345) was obtained from Open Biosystems (Huntsville, AL). The cDNA plasmid encoding a COOH-terminal green fluorescent protein (GFP)-fusion hSLC26A2-GFP (gift of J. Schwartzbauer, Princeton University) was subcloned into pXT7.
hSLC26A2 mutations R297W and A386V were generated by four primer polymerase chain reaction (PCR) as described (8) with specific mutagenic oligonucleotides and flanking oligonucleotides hA2-F and hA2-R (see supplemental Table 1 online at the AJP-Cell Physiology website). All PCR products were sequenced in entirety in both strands to ensure absence of unintended mutations.
Expression of cRNAs in Xenopus oocytes. Capped cRNA was transcribed from linearized cDNA templates with T7 or SP6 RNA polymerase (Ambion, Austin, TX) and purified with an RNeasy mini-kit (Qiagen). cRNA concentration (A 260) was measured by Nanodrop spectrometer (ThermoFisher), and integrity was confirmed by formaldehyde agarose gel electrophoresis. Mature female Xenopus (Dept. of Systems Biology, Harvard Medical School; or NASCO, Madison, WI) were maintained and subjected to partial ovariectomy under hypothermic tricaine anesthesia following protocols approved by the Institutional Animal Care and Use Committee of Beth Israel Deaconess Medical Center. Stage V-VI oocytes were prepared by overnight incubation of ovarian fragments in MBS with 1.3 mg/ml collagenase B (Roche, Indianapolis, IN), followed by a 20-min rinse in Ca 2ϩ -free MBS with subsequent manual selection and defolliculation as needed. Oocytes were injected on the same day with cRNA (0.5-50 ng) or with water in a volume of 50 nl. Injected and uninjected oocytes were then maintained before use for 2-6 days at 19°C in MBS containing gentamicin. Injection of increasing amounts of hSLC26A2-GFP cDNA led to corresponding increases in GFP fluorescence intensity at or near the oocyte surface (see supplemental Fig. 1 online at the AJP-Cell Physiology website). Injection of increasing amounts of untagged hSLC26A2 also led to corresponding increases in transporter polypeptide at or near the oocyte surface, as detected by confocal immunofluorescence microscopy (see supplemental Fig. 2 (6) . 35 SO 4 2Ϫ uptake increased as a function of the amount of cRNA previously injected (supplemental Fig. 1 ). 36 Cl Ϫ influx studies were carried out for periods of 15 or 30 min in ND-96 as previously described (7) Influx experiments were terminated with four washes in Cl Ϫ -free ND96, followed by oocyte lysis in 150 l of 2% sodium dodecyl sulfate (SDS). Duplicate 10-l aliquots of influx solution were used to calculate specific activity of radiolabeled substrate anions. Oocyte anion uptake was calculated from oocyte-associated counts per minute (cpm) and bath specific activity.
Isotopic efflux experiments. For unidirectional 36 Cl Ϫ efflux studies individual oocytes in Cl Ϫ -free ND-96 were injected with 50 nl of 260 mM Na 36 Cl (20,000 -24,000 cpm). After a 5-to 10-min recovery period in Cl Ϫ -free ND-96, the efflux assay was initiated by transfer of individual oocytes to 6-ml borosilicate glass tubes, each containing 1 ml efflux solution. At intervals of 1 or 3 min, 0.95 ml of this efflux solution was removed for scintillation counting and replaced with an equal volume of fresh efflux solution. After completion of the assay with a final efflux period either in Cl Ϫ -free cyclamate solution or in the presence of the inhibitor DIDS (100 or 200 M), each oocyte was lysed in 150 l of 2% SDS. Samples were counted for 3-5 min such that the magnitude of 2SD was Ͻ5% of the sample mean.
For [ 14 C]oxalate efflux assays, oocytes were injected with 50 nl of 50 mM Na [
14 C]oxalate (6,000 -8,000 cpm, with final estimated intracellular concentration 5 mM). After a recovery period of at least 20 min, efflux was measured in baths containing up to 103.6 mM NaCl or 64 mM Na2SO4, or as indicated. In baths of reduced [Cl Ϫ ] or [SO 4 2Ϫ ] the respective anions were replaced with equimolar cyclamate. Bath anion concentration-response curves were generated from individual oocytes subjected sequentially to increasing concentrations of the bath anion under study. Single oocytes were exposed to a maximum of six conditions.
To vary pHi, oocytes were preexposed to 40 mM Na butyrate (substituting for Na cyclamate) for 30 min before initiation of an efflux experiment to produce intracellular acidification to pHi 6.8. Upon removal of bath butyrate (with substitution by Na cyclamate) during the efflux experiment, pHi rapidly alkalinized back toward initial pHi while pHo remained constant. Variation of pHo was achieved at near-constant pHi (39) . Some oocyte groups were exposed to 20 mM NH4Cl during the efflux experiments, acidifying pHi to 6.9 (26) . Drugs were added to the bath or were injected into oocytes either before or together with an isotope as indicated.
Efflux data were plotted as the natural logarithm (ln) of the quantity (%cpm remaining in the oocyte) versus time. Efflux rate constants for 35 SO 4 2Ϫ , 36 Cl Ϫ , and [ 14 C]oxalate were measured from linear fits to data from the last three time points sampled within each experimental period. For each experiment, water-injected or uninjected oocytes from the same frog were subjected to parallel measurements with cRNA-injected oocytes. Each experimental condition was tested in oocytes from at least two frogs. Two exclusion criteria were defined to categorize efflux experiments as reflecting "nonspecific" efflux or "leaky" oocytes. One criterion was Ͻ50% reduction in efflux rate constant upon final addition of the inhibitor DIDS or upon final bath substitution of exchangeable substrate anion for the impermeant anion, cyclamate. The second criterion was loss of Ͼ85% of injected isotope before completion of the efflux assay.
Application of these a priori criteria resulted in exclusion from analysis of 11% of 176 36 Cl Ϫ -injected oocytes, 12% of 330 35 SO 4 2Ϫ -injected oocytes, and 15% of 683 [
14 C]oxalate-injected oocytes. Two-electrode voltage-clamp measurements. Microelectrodes from borosilicate glass made with a Sutter P-87 puller were filled with 3 M KCl and had resistances of 2-3 M⍀. Oocytes previously injected with water or with 10 ng of the indicated cRNA were placed in a 1-ml chamber (model RC-11, Warner Instruments, Hamden, CT) on the stage of a dissecting microscope and impaled with microelectrodes under direct view. Steady-state currents achieved within 2-5 min following bath change or drug addition were measured with a Geneclamp 500 amplifier (Axon Instruments, Burlingame, CA) interfaced to an Dell computer with a Digidata 1322A digitizer (Axon). Standard recording bath solution was (in mM) 93.5 NaCl, 2 KCl, 5 HEPES, 2.8 MgCl 2, pH 7.40, or occasionally ND-96. In anion substitution experiments NaCl was replaced with Na cyclamate, with addition of 5 mM sulfate or oxalate. In some experiments, 96 mM NaCl was replaced with 64 mM Na 2SO4
2Ϫ . Bath addition of 5 mM Na oxalate was performed in the presence of nominally Ca 2ϩ -free cyclamate solution.
Data acquisition and analysis utilized pCLAMP 8.0 software (Axon). The voltage pulse protocol generated with the Clampex subroutine consisted of 20-mV steps between Ϫ100 mV and ϩ40 mV, with durations of 738 ms separated by 30 ms at the holding potential of Ϫ30 mV. Bath resistance was minimized by the use of agar bridges filled with 3 M KCl, and a virtual ground circuit clamped bath potential to zero during voltage-clamp experiments.
Confocal immunofluorescence microscopy. Two days after injection with H 2O or with cRNA encoding COOH terminally GFP-tagged hSLC26A2, 10 -12 oocytes were fixed in 3% paraformaldehyde (PFA) in phosphate-buffered saline (PBS) for 30 min at room temperature, washed three times in PBS supplemented with 0.002% Na azide (PBS-azide), and saved at 4°C for direct imaging of GFP. Oocytes were aligned in uniform orientation along a Plexiglas groove and sequentially imaged through the ϫ10 objective of a Zeiss LSM510 laser scanning confocal microscope using the 488-nm laser line at 512 ϫ 512 resolution at a uniform setting of 80% intensity, pinhole 61 m (1.0 Airy units), detector gain 650, Amp gain 1, 0 amp offset.
Two or three days after injection with H 2O or with cRNA encoding wild-type or mutant untagged hSLC26A2, groups of 10 -12 oocytes were similarly fixed with 3% PFA and washed with PBS-azide. Oocytes were then placed in PBS containing 1% SDS to permeabilize the surface membranes and unmask epitope. Fixed, permeabilized oocytes were blocked in PBS with 1% bovine serum albumin (PBS-BSA) containing 0.05% saponin for 1 h at 4°C and then washed three times with PBS-BSA. Oocytes were incubated overnight at 4°C with mouse monoclonal anti-hSLC26A2 antibody I-G2 at 1:400 dilution in PBS-BSA (28) and then washed three times in cold PBS-BSA. Ϫ at the indicated concentrations for (n) oocytes compared with complete inhibition by DIDS (200 M). Oocytes previously injected with 50 ng cRNA or water were subjected to 30 min uptake in the presence of 1 mM extracellular SO 4 2Ϫ . Uptake data were normalized to same-day experiments carried out in cyclamate. Solid bar indicates water-injected oocytes. Normalized uninhibited SO 4 2Ϫ uptake was (in nmol/ oocyte Antibody-labeled oocytes were then incubated 2 h with Cy3-conjugated secondary goat anti-mouse Ig (dilution 1:500, Jackson Immunochemicals), again thoroughly washed in PBS-BSA, and stored at 4°C until imaging.
Cy3-labeled oocytes were aligned in uniform orientation along a Plexiglas groove and sequentially imaged through the ϫ10 objective of a Zeiss LSM510 laser scanning confocal microscope by using the 543-nm laser line at 512 ϫ 512 resolution at a uniform setting of 80% intensity, pinhole 54 (1.0 Airy units), detector gain 650, Amp gain 1, 0 amp offset.
Polypeptide abundance at or near each oocyte surface was estimated by quantitation of specific fluorescence intensity (FI) at the circumference of one quadrant of an equatorial focal plane (Image J v. (Fig. 1B) , and mSlc26a2 showed similar results (Fig. 1D) . Cis-inhibition by 24 mM HCO 3 Ϫ was 20% for hSLC26A2 and 45% by mSlc26a2. 35 
2Ϫ influx by both orthologs was completely inhibited in the presence of 200 M DIDS (Fig. 1D and data not shown), consistent with previous reports (29, 37) . Inhibition by DIDS (12 min exposure) was only partially reversible, whereas the lower affinity inhibition by DNDS was completely reversible (supplemental Fig. 3 (Fig. 5, A and B) . The low affinity for extracellular Cl Ϫ was also evident in measurements of hSLC26A2-mediated 36 Cl Ϫ efflux into the Cl . In oocytes expressing mSlc26a2 or hSLC26A2, 36 Cl Ϫ influx in exchange for intracellular anion (nominal Cl Ϫ ) was also linear and nonsaturable out to 104 mM (supplemental Fig. 4, A and C Fig. 4, B and D) or saturating extracellular [oxalate] (data not shown) were 10-to 30-fold lower (supplemental Fig. 4, C-F) than that of 36 Cl Ϫ efflux into 104 mM extracellular Cl Ϫ (Fig.  5, C and D) . Nonetheless, the K 1/2 values for extracellular SO 4 2Ϫ and oxalate at these low exchange rates were similar to those measured at the higher transport rates of the respective isotopically labeled anions. Thus the intracellular Cl Ϫ binding site of SLC26A2 exhibits highly specific trans-anion dependence. Occupancy of the intracellular anion binding site of SLC26A2 by 36 Cl Ϫ allows robust 36 (30) . Figure 6A shows that addition of 5 mM oxalate (a saturating concentration) to hSLC26A2-expressing oocytes in a Cl Ϫ -free gluconate bath produces no detectable increase of outward current (Fig. 6A) . Figure 6B shows , but efflux rapidly accelerated more than 10-fold upon bath pH elevation to 8.0 (SO 4 2Ϫ i /Cl o Ϫ exchange). The faster efflux did not represent nonspecific leak, since it remained sensitive to inhibition by DIDS (Fig. 7, A and B) . Inhibition of hSLC26A2 by acidic pH o also applied to efflux of 36 Fig. 8, A and B. However, hSLC26A2 was nearly or completely pH i insensitive when it mediated efflux of 36 Cl i Ϫ (Fig. 8C) However, Fig. 9 demonstrates that extracellular butyrate did not itself serve as a substrate for hSLC26A2-mediated exchange with 35 SO 4 2Ϫ , whereas subsequent introduction of bath Cl Ϫ elicited robust 35 SO 4 2Ϫ efflux activity sensitive to DIDS.
Exposure of oocytes to 20 mM NH 4 Cl also acidifies pH i (ϳ0.4 pH units) (4, 26, 36) , likely reflecting a native ratio of NH 4 ϩ /NH 3 permeabilities higher than that of mammalian tissue culture cells. This route of intracellular acidification, in con- trast to butyrate, inhibited hSLC26A2-mediated efflux of 35 Fig. 6D ). Thus, as observed previously for other anion exchangers (26) , NH 4 ϩ regulates SLC26A2 by a mechanism likely distinct from that mediating regulation by pH i .
The anion substrate-selective pH i -sensitivity phenotype observed for hSLC26A2 has not been previously described among SLC26 transporters. It also contrasts remarkably with the pH sensitivity of anion exchange mediated by Slc4a2/Ae2, which is inhibited by both intracellular and extracellular protons acting through distinct structural elements of the polypeptide (39) .
PKC inhibits hSLC26A2 through reduction of surface expression. Phorbol ester-sensitive PKC inhibits mSlc26a6 activity, largely through reduction in oocyte surface expression, whereas hSLC26A4/pendrin lacks this response to PKC (21) . We reproduced this pattern of hSLC26A6 regulation by PKC (data not shown) and then tested the response of hSLC26A2 to PKC. As shown in Fig. 10, A and B , exposure to the classical PKC activator PMA in the absence of bath Cl Ϫ dramatically reduced subsequent 35 SO 4 2Ϫ efflux after reintroduction of bath Cl Ϫ , whereas exposure to the inactive PMA analog 4␣-PDD was without effect. PKC activation was associated with reduced abundance of hSLC26A2-GFP at or near the oocyte surface, as shown in Fig. 10, C and D . Again, 4␣-PDD was without effect. Thus PKC inhibits hSLC26A2/ DTDST largely by reducing its abundance at the cell surface, similar to its regulation of mSlc26a6.
DTDST mutations inhibit hSLC26A2 activity at the cell surface or by regulating surface abundance. Mutations in hSLC26A2/DTDST cause several related clinical phenotypes of chondrodysplasia (22, 35) . A related murine phenotype was generated by genetic knock-in of a mutation homologous to a human mutation associated with disease of moderate severity (10, 14) . The several hSLC26A2 disease mutations that have been subjected to functional study exhibited decreased SO 4 2Ϫ uptake into oocytes (29) or HEK-293 cells (28) . We therefore compared the effects of chondrodysplasia mutations on oxalate and SO 4 2Ϫ transport. The severe hSLC26A2 mutation R279W impaired uptake of 35 SO 4 2Ϫ (Fig. 11A) , as described earlier (28, 29) . Uptake of [
14 C]oxalate was reduced to a comparable degree (Fig. 11B) . The mutation A386V, analogous to that in the Slc26 mutant mouse (14) but not yet tested functionally, was associated with less severely reduced uptake of both 35 SO 4 2Ϫ and [ 14 C]oxalate (Fig. 11, A and B) . The impaired function of mutant A386V was largely secondary to reduced surface abundance of mutant polypeptide, whereas that of mutant R279W exhibited near wild-type surface abundance despite impaired SO 4 2Ϫ uptake activity (Fig. 11, C and D) .
DISCUSSION
SLC26A2 was the first human member of the SulP gene superfamily linked to human genetic disease. Its homology with the previously identified SO 4 2Ϫ uptake transporters hSAT-1 and sulfate permease II of Neurospora crassa led to the demonstration of loss of SO 4 2Ϫ uptake by primary fibroblasts from a patient with diastrophic dysplasia (DTD) (22) . Subsequent studies of recombinant SLC26A2 documented SO 4 2Ϫ transport, defined cis-inhibitor anions (37) and K 1/2 for extracellular SO 4 2Ϫ in Xenopus oocytes, and documented reduced SO 4 2Ϫ uptake by most SLC26A2 mutants of DTD patients in oocytes and HEK-293 cells (28, 29) .
In the current paper, we have extended the functional characterization of SLC26A2. We establish that hSLC26A2 and mSlc26a2 mediate bidirectional anion exchange with similar characteristics. We find that SLC26A2 transports oxalate and Cl Ϫ (in addition to SO 4
2Ϫ
) by an apparently electroneutral mechanism. We show that SLC26A2 is regulated independently by pH o , pH i , NH 4 ϩ , and PKC, and that disease mutations alter oxalate transport in parallel with SO 4 2Ϫ transport. We also report anion substrate-selective asymmetries of anion exchange.
Lack of species differences. The 78% amino acid sequence identity between mSlc26a6 and hSLC26A6 is associated with substantial differences in anion transport selectivity and affinity (6, 8) . Thus the 80% amino acid sequence identity between mSlc26a2 and hSLC26A2/DTDST similarly prompted us to compare functional properties of these two species orthologs. In contrast to anion transport by SLC26A6, we found that anion transport by mouse and human SLC26A2 did not differ in their tested transport properties. This functional similarity strengthens the possibility that study of mSlc26a2 and the hypomorph knock-in mouse (14) will continue to provide data applicable to hSLC26A2 and its deficiency diseases.
Oxalate transport by wild-type and mutant SLC26A6. The expression of mSlc26a2 polypeptide in the apical pole of colonocytes (20) prompted us to test it as an oxalate transporter possibly contributing to oxalate absorption or to the 25-50% of transepithelial oxalate secretion that is mSlc26a6 independent (15, 27 uptake but less potently (Fig. 1B) than previously noted.
SLC26A2 is abundant in chondrocytes, suggesting the possibility of chondrocyte involvement in primary hyperoxaluria. Oxalosis can indeed involve bones, joints (32) , and skin (40), but oxalate transport by chondrocytes and fibroblasts has not yet been reported. Urinary oxalate excretion has not been measured in the Slc26a2 hypomorph mutant mice, in which nephrocalcinosis has not been radiologically evident (A. Rossi, University of Pavia, personal communication).
SLC26A2 chondrodysplasia mutant polypeptides have been shown previously to exhibit varying degrees of decreased SO 4 2Ϫ transport. We studied two human disease mutations, one of which (A386V) corresponds to the mouse knock-in hypomorph mutation but had not been studied as an anion transporter. We found that transport of SO 4 2Ϫ and oxalate was reduced in parallel for both mutants, but that only A386V exhibited parallel reduction in abundance at or near the oocyte surface. The reduced function of the R279W mutant in the setting of apparently wild-type surface abundance suggests that the mutation reduces the rate of the conformational cycle that mediates anion transport. The R279W mutant should thus prove a useful point of entry for future structure-function studies of SLC26A2. (Fig. 4D) (Fig. 6 ). An electrogenic SLC26A2-mediated SO 4 2Ϫ influx of magnitude equivalent to that measured in Fig. 1 should be reflected in a DIDS-sensitive outward current of 30 -40 nA at the resting potential of approximately Ϫ30 to Ϫ40 mV. This level of current is detectable by two-electrode voltage clamp at that potential but was not evident (Fig. 6) . We therefore conclude that Fig. 2 should be reflected in an outward current of only 4 nA at resting potential. This level of current is below the detection threshold (Fig. 6) . Thus our present results do not allow a definitive conclusion that SLC26A2-mediated oxalate o /Cl i exchange is electroneutral. Nonetheless, SLC26A2-mediated oxalate/Cl Ϫ exchange and SO 4 2Ϫ /Cl Ϫ exchange likely employ the same mechanism. In contrast, electrogenic oxalate/Cl Ϫ exchange has been observed in oocytes expressing mSlc26a6 (8) , nonmammalian orthologs of Slc26a5/prestins (38) , and rat Slc26a1/Sat-1 (30 14 C]oxalate uptake by (n) uninjected oocytes or oocytes expressing WT or mutant hSLC26A2 (50 ng cRNA). WT uptake was 0.20 Ϯ 0.02 nmol/h. C: confocal immunofluorescence micrographs of representative oocytes expressing WT hSLC26A2 or the indicated mutants. D: normalized mean fluorescence intensity (FI) measured at the periphery of (n) oocytes expressing WT or mutant SLC26A2. WT hSLC26A2 intensity was assigned a mean FI of 1.0. ***P Ͻ 0.001. exhibits substrate selectivity, but not of the same type as regulation by pH i (supplemental Fig. 6 ).
Inhibition by acidic pH o is of pathophysiological importance in the hypoxic and elevated lactate conditions of inflamed and septic joints. Septic or inflammatory joint synovial fluid pH can reach pH 6.6 or below (42) . The cells of the hypoxic nucleus pulposus of vertebral bodies lack carbonic anhydrase activity and exhibit resting pH i of 6.7, with pH o as low as 6.4 (34) . In this acidic environment, reduced SLC26A2-mediated SO 4 2Ϫ transport by fibroblasts and chondrocytes in these acidic environments could thus impair local glycosaminoglycan biosynthesis. However, potential activation of SO 4 2Ϫ uptake by acidic pH i could counter this impairment, suggesting a balance of two counter-regulatory effects.
PKC activation markedly inhibits SLC26A2, in part by reducing its abundance at the oocyte surface. This mode of regulation resembles that previously shown for the apical anion exchanger SLC26A6 but is unlike the insensitivity to PKC shown by the apical anion exchanger SLC26A4/pendrin (21) . Thus activation of chondrocyte SLC26A2 through administration of PKC inhibitors might be envisioned as a useful component of treatment for degenerative joint diseases. Future experiments could determine the specific PKC type involved in regulation of SLC26A2.
Possible roles of SLC26A2 in intestine and kidney. Although SLC26A2 can exchange oxalate, it is likely a minor contributor to intestinal transepithelial transport of oxalate under normal conditions. The strong DIDS sensitivity of all SLC26A2 transport modes does not support its contribution to DIDS-insensitive intestinal oxalate absorption (23) . In oocytes, SLC26A2-mediated oxalate influx and efflux were both at considerably lower rates than SLC26A6-mediated oxalate influx and efflux (6, 8) . Moreover, small interfering RNA (siRNA) knockdown of hSLC26A6 by ϳ60% in Caco2 cells decreased unidirectional oxalate fluxes in both directions by 50% (16) Fig. 6D ) but reduced by mildly acidic intestinal lumenal pH (Fig. 7) .
However, hSLC26A2 could mediate a significant portion of that oxalate secretion dependent on exchange with luminal SO 4 2Ϫ , and this exchange mode might be sensitive to inhibition by both the mildly acidic lumenal pH and the elevated [NH 4 ϩ ] of the colon. Although median [SO 4 2Ϫ ] in municipal water supplies was 0.28 mM, [SO 4 2Ϫ ] in private well water can exceed 20 mM (11, 19) , and common dietary sources rich in SO 4 2Ϫ include preserved fruits, Brassica vegetables, and beer. SLC26A2 might thus, also serve, in states of positive SO 4 2Ϫ balance, to secrete SO 4 2Ϫ in exchange for lumenal Cl Ϫ , complementing renal SO 4 2Ϫ excretion.
hSLC26A2 mRNA levels have been suggested as a biomarker for the differential diagnosis of Crohn's disease and ulcerative colitis. SLC26A2 mRNA levels are increased severalfold in Crohn's disease and unchanged or strongly decreased in ulcerative colitis (9, 43) . SLC26A2 and SLC6A14 mRNA levels used as part of a seven gene panel yielded rates of correct prediction, sensitivity, and specificity higher than with previously available diagnostic indices (43) . In addition, SLC26A2 is downregulated in colon cancer biopsies compared with surrounding normal tissue (18) .
SLC26A2 mRNA is expressed in the kidney, and SLC26A2 polypeptide has been immunolocalized in the brush border of the rat proximal tubule (5) . In that location, oxalate/SO 4 2Ϫ exchange by SLC26A2 might contribute to tertiary active Cl Ϫ reabsorption across the proximal tubular epithelium, coupled to sodium-sulfate cotransport (1) .
